1. Home
  2. CTSO vs CIGL Comparison

CTSO vs CIGL Comparison

Compare CTSO & CIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.61

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

CIGL

Concorde International Group Ltd Class A Ordinary Shares

HOLD

Current Price

$1.99

Market Cap

417.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTSO
CIGL
Founded
1997
1997
Country
United States
Singapore
Employees
N/A
134
Industry
Medical/Dental Instruments
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
38.2M
417.7M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CTSO
CIGL
Price
$0.61
$1.99
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$5.38
N/A
AVG Volume (30 Days)
100.2K
45.1K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
65.79
N/A
EPS
N/A
N/A
Revenue
$22,503,908.00
N/A
Revenue This Year
$10.34
N/A
Revenue Next Year
$22.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.53
N/A
52 Week Low
$0.50
$1.40
52 Week High
$1.39
$25.00

Technical Indicators

Market Signals
Indicator
CTSO
CIGL
Relative Strength Index (RSI) 46.17 56.54
Support Level $0.50 $1.55
Resistance Level $0.74 $2.28
Average True Range (ATR) 0.05 0.16
MACD 0.00 0.01
Stochastic Oscillator 62.45 69.49

Price Performance

Historical Comparison
CTSO
CIGL

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

About CIGL Concorde International Group Ltd Class A Ordinary Shares

Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.

Share on Social Networks: